Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study

[1]  F. Chauvin,et al.  Meta-analysis of randomised trials of systemic chemotherapy versus supportive treatment in non-resectable non-small cell lung cancer. , 1995, Lung cancer.

[2]  P. Ellis,et al.  Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer. , 1995, British Journal of Cancer.

[3]  F. Invernizzi,et al.  Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature. , 1994, Chest.

[4]  F. M. Hack,et al.  Modulation of intrinsic in vitro resistance to carboplatin by edatrexate in the A549 human nonsmall cell lung cancer cell line. , 1994, Oncology research.

[5]  G Cartei,et al.  Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer. , 1993, Journal of the National Cancer Institute.

[6]  M. Kris,et al.  Edatrexate, an antifolate with antitumor activity: a review. , 1993, Cancer investigation.

[7]  S. Lippman,et al.  Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer. , 1992, Journal of the National Cancer Institute.

[8]  K. Propert,et al.  Carboplatin in non-small cell lung cancer: an update on the Cancer and Leukemia Group B experience. , 1992, Seminars in oncology.

[9]  K. Propert,et al.  A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. , 1990, The New England journal of medicine.

[10]  J. Sculier,et al.  A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  D. Finkelstein,et al.  Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J L Pater,et al.  Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M. Kris,et al.  Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  D. Ettinger,et al.  Phase II trial of carboplatin in non-small cell lung cancer. , 1986, Cancer treatment reports.